Allosteric Ligand Design Services

* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.

Most targeted protein degradation programs begin at the orthosteric pocket, because that is where validated ligands already exist. That route stalls when the active site is highly conserved across a protein family, when it is permanently occupied by a high-concentration natural ligand, or when resistance mutations have already eroded inhibitor binding. An allosteric warhead changes the starting point: it engages a regulatory pocket, an interdomain interface, or a cavity that opens only in one conformational state, and it places the E3 ligase on a different face of the target.

BOC Sciences provides allosteric warhead design services for PROTAC and degrader programs, connecting pocket identification, conformational analysis, ligand discovery, biophysical validation, and structure-guided optimization in a single workflow. Every candidate is judged against the geometry a productive ternary complex actually requires, so a warhead that looks good in a binding assay does not become a conjugate that degrades nothing.

Request a Consultation Explore Services
Overview

What Is an Allosteric Warhead in Targeted Protein Degradation?

An allosteric warhead is a target-binding ligand that recognizes a regulatory site outside the protein's conventional orthosteric binding pocket. Upon binding, it may induce or stabilize conformational changes that alter protein surface topology and interactions with other proteins, potentially influencing E3 ligase recruitment, ternary complex formation, and target ubiquitination. Compared with orthosteric warheads, allosteric warheads offer alternative binding opportunities that may improve target subtype selectivity and help overcome resistance-associated mutations affecting orthosteric sites.

Services

BOC Sciences Allosteric Warhead Design Services for PROTAC Development

Our service is organized around the sequence a warhead actually travels: find the pocket, find a binder, prove where it binds, then optimize it for a degrader rather than for an inhibitor.

Gene Therapy

Allosteric and Cryptic Pocket Identification

Identifying a suitable binding site is the foundation of allosteric warhead development. BOC Sciences evaluates target protein structures and conformational features to identify potential non-orthosteric binding regions that can support ligand recognition and subsequent PROTAC construction. Our analysis considers both established allosteric pockets and cryptic cavities that may become accessible during protein conformational changes.

  • Structural pocket mapping: Analyze experimentally determined and modeled protein structures to identify surface cavities, regulatory pockets, interdomain regions, and potential ligand-binding hotspots.
  • Dynamic pocket identification: Investigate conformational ensembles and transiently accessible cavities to identify cryptic pockets that may not be apparent in a single static structure.
  • Allosteric communication assessment: Evaluate potential relationships between candidate binding sites and distant catalytic, regulatory, or protein-interaction regions.
  • Druggability prioritization: Assess pocket geometry, residue composition, solvent accessibility, hydrophobic and polar characteristics, and potential ligand-binding interactions.
Gene Therapy

Allosteric Ligand Discovery and Hit Screening

BOC Sciences develops customized ligand discovery strategies based on target structure, pocket characteristics, available chemical resources, and the intended PROTAC application. The objective is to identify compounds with experimentally supportable target engagement and chemical features suitable for further warhead optimization.

  • Structure-based virtual screening: Screen compound collections against prioritized allosteric pockets using docking, binding-pose analysis, and interaction scoring.
  • Fragment-based discovery: Identify small molecular fragments that interact with potential allosteric hotspots and provide starting points for hit expansion and optimization.
  • Biophysical and biochemical screening: Evaluate candidate compounds for target binding and investigate their concentration-dependent interaction behavior.
  • Hit selection and prioritization: Compare binding evidence, structural complementarity, selectivity, physicochemical properties, and chemical tractability to select promising candidates.
Gene Therapy

Binding-Mode Characterization

Understanding how a candidate ligand interacts with its target is essential for determining whether it is suitable for conversion into an allosteric warhead. BOC Sciences combines computational analysis and experimental characterization to investigate ligand-binding orientation, key amino acid interactions, and the structural features that influence target engagement.

  • Binding-site confirmation: Determine whether a candidate engages the intended non-orthosteric pocket and distinguish its binding behavior from interactions at conventional functional sites.
  • Interaction mapping: Analyze hydrogen bonds, hydrophobic contacts, electrostatic interactions, aromatic interactions, and key residue contributions to ligand recognition.
  • Binding affinity and kinetics: Evaluate concentration-dependent binding, apparent affinity, association behavior, and dissociation characteristics where appropriate.
  • Structural pose validation: Integrate computational binding models with available structural and experimental evidence to assess the reliability of the proposed ligand orientation.
Gene Therapy

Structure-Guided Warhead Optimization

BOC Sciences uses structure-guided design and structure-activity relationship analysis to improve ligand performance while preserving the interactions required for target engagement.

  • Scaffold optimization: Modify substituents, ring systems, heteroatom positions, and functional groups to improve binding interactions and molecular properties.
  • Exit-vector identification: Identify solvent-exposed or otherwise suitable ligand positions for linker attachment while minimizing disruption of key target-binding interactions.
  • Structure-activity relationship analysis: Compare analogues to determine how chemical modifications influence binding affinity, selectivity, and binding-pose stability.
  • PROTAC compatibility optimization: Evaluate how linker attachment and molecular extension affect warhead recognition, solubility, permeability, and overall degrader design.
Platforms

Technologies and Methods for Allosteric Warhead Design and Optimization

Allosteric warhead development generally follows two complementary routes: repurposing an established allosteric ligand or discovering a new ligand for a previously unexplored binding site. The appropriate approach depends on the target, the availability of structural information, existing chemical matter, and the accessibility of experimental screening systems. BOC Sciences applies different computational and experimental methods to these two starting points, with a common objective of obtaining a validated target-binding ligand suitable for PROTAC development.

Existing Allosteric Inhibitor-Based Warhead Design

When established allosteric ligands are available for a target, BOC Sciences evaluates these ligands and their inhibitor-derived scaffolds through a structure-guided modification strategy. This involves reviewing available protein-ligand structures, key binding residues, reported structure-activity relationships, and the chemical features responsible for target recognition.

  • Known ligand assessment: Review existing allosteric inhibitors and target-binding compounds to identify promising scaffolds and evaluate their potential as degrader warheads.
  • Binding-pose and interaction analysis: Examine the ligand orientation, key residue contacts, pocket occupancy, and structural regions that may tolerate modification.
  • Exit-vector selection: Identify solvent-exposed attachment positions that allow linker extension without disrupting critical target-binding interactions.
  • Warhead derivatization: Introduce suitable chemical modifications to improve linker attachment compatibility while maintaining the original binding mode.
  • Affinity retention assessment: Compare the parent ligand and modified warhead to determine whether chemical conjugation affects target engagement.

Active Discovery of Novel Allosteric Ligands

When a target lacks a suitable known allosteric inhibitor or established non-orthosteric ligand, BOC Sciences develops target-specific discovery strategies that combine computational screening, fragment-based approaches, and experimental binding evaluation. The methods are selected according to the structural characteristics of the target, the availability of purified protein or suitable biological models, and the properties of the candidate binding pocket.

  • Structure-based virtual screening: Use predicted or experimentally determined protein structures to screen compound collections against prioritized allosteric pockets.
  • Fragment-based discovery: Identify small fragments that occupy individual pocket hotspots and use them as starting points for fragment growth, linking, or scaffold elaboration.
  • Biophysical screening: Detect direct ligand-protein interactions using suitable techniques such as surface plasmon resonance, microscale thermophoresis, NMR, or thermal stability analysis.
  • Biochemical and functional screening: Investigate whether candidate ligands influence target activity or regulatory behavior, while distinguishing functional modulation from direct binding evidence.
  • Hit confirmation and optimization: Validate selected compounds through orthogonal assays, investigate their binding modes, and prioritize candidates for further warhead development.

Need to Discover or Optimize a Suitable Ligand for Your Target Protein?

BOC Sciences offers ready-to-screen ligand libraries and integrated computational and experimental platforms to support allosteric ligand discovery, screening, binding validation, and structural optimization. Let our experts help identify and optimize suitable ligands for your target protein.

Find Your Allosteric Ligand

Allosteric Sites

Allosteric Site Classes We Design Warheads For

Identifying the appropriate site class helps determine which ligand discovery methods and structural optimization strategies are most suitable for a particular target. BOC Sciences evaluates the biological and structural characteristics of each candidate site before prioritizing it for allosteric warhead development.

Gene Therapy

ATP-Adjacent Allosteric Pockets in Kinases

Type III ligands occupy a hydrophobic pocket beside the ATP site without entering the adenine region. The geometry is the point: the linker leaves the kinase from a face an ATP-competitive warhead never uses, so a target that forms unproductive ternary complexes with orthosteric binders can become degradable. MEK1/2 is the reference case, and allosteric MEK ligands have repeatedly supported efficient degradation.

  • Selectivity lever: these pockets diverge far more than the ATP cleft across the kinome.
  • Conformation dependence: pocket shape shifts with activation state, so structural confirmation is not optional.
  • Design caution: affinity is usually lower than for ATP-site ligands, and the ternary complex must compensate.
Gene Therapy

Distal Regulatory Pockets in Enzymes and Signaling Proteins

Distal sites sit far from the catalytic center and control activity through long-range coupling: autoinhibitory domain interfaces, interdomain allosteric tunnels, myristoyl pockets in the C-terminal lobe, and flap subdomains in phosphatases. Because they belong to the least conserved part of the surface, they offer the strongest selectivity available within a target family.

  • State locking: occupancy can trap an autoinhibited conformation that presents a more favorable ubiquitination surface.
  • Ensemble requirement: these pockets often open in only one state, so single-structure docking produces false negatives.
  • Documented starting points: phosphatase tunnel binders and myristoyl-pocket ligands have both been converted into degrader warheads.
Gene Therapy

Endogenous Ligand-Binding Pockets with Allosteric Function

Cavities that normally hold lipids, metabolites, or cofactors are attractive because nature has already established that they are ligandable. The TEAD palmitate pocket and the HIF-2α PAS-B cavity are the best-known examples, and both have produced allosteric ligands that support degradation. The recurring constraint is burial: very few atoms point toward solvent.

  • Context-dependent availability: lipidation state, dimerization, and chromatin association can each change whether the pocket is open.
  • Exit vector is the hard part: linkers may need to be longer and more polar to escape the cavity before reaching the E3 ligase.
  • Early property work: endogenous-ligand mimics are often lipophilic, which pushes polarity correction forward in the program.
Gene Therapy

Protein-Protein Interaction Interfaces with Allosteric Coupling

Some of the most selective handles are not cavities at all. Dimerization surfaces, cofactor grooves, and substrate-recruitment sites are flat, shallow, and often partly disordered, yet binding at a single hot spot can propagate a conformational change across the interface. Warheads for this class come from peptidomimetics, conformationally constrained peptides, and fragments that stabilize one interface state.

  • Hot-spot mapping first: energetic decomposition of the interface before any library is screened.
  • Permeability as gatekeeper: peptide-derived warheads need conformational constraint or backbone modification before cell-based work.
  • Conjugation chemistry: peptide warheads accept different handles, which changes the linker chemistry available through peptide ligand for target protein design.

Is the Orthosteric Site of Your Target Unsuitable for PROTAC Development?

Considering an Allosteric Site as an Alternative? Share your target protein and current design challenges with BOC Sciences. Our experts can help evaluate orthosteric and allosteric binding opportunities, identify alternative target-binding sites, and explore suitable strategies for PROTAC development.

Discuss Your Target

Troubleshooting

Design Challenges We Solve in Allosteric Warhead Programs

Allosteric warhead development involves challenges that are not always encountered in conventional ligand optimization. A candidate may show measurable binding but interact with a shallow pocket, recognize only a transient protein conformation, or lose affinity after linker attachment. Even when target engagement is retained, the resulting PROTAC may fail to form a productive ternary complex. BOC Sciences considers these factors throughout ligand discovery and optimization to help researchers identify the underlying causes of poor warhead performance.

Shallow Pockets with Weak Starting Affinity

Some allosteric sites have limited pocket depth, incomplete enclosure, or relatively few strong interaction hotspots. These structural characteristics can make it difficult to identify ligands with sufficient binding affinity and stable molecular recognition. Small fragments may interact with individual residues but fail to establish enough complementary contacts to support further PROTAC development.

BOC Sciences addresses this challenge through detailed pocket analysis and fragment-oriented optimization. We evaluate the distribution of hydrophobic and polar residues, identify interaction hotspots, and investigate whether ligand growth or scaffold modification can improve molecular complementarity.

Pockets That Exist Only in a Transient Conformational State

Certain allosteric and cryptic pockets are not consistently visible in static protein structures. They may emerge when domains move, loops rearrange, or local side-chain conformations change. A ligand designed against a single predicted structure may therefore fail to recognize the target in its predominant or biologically relevant conformational state.

Our approach incorporates conformational analysis to investigate pocket accessibility across multiple structural states. Molecular dynamics simulations and comparative structural assessment can help identify transient cavities, characterize their opening and closing behavior, and determine which conformations may be suitable for ligand recognition.

Flat Aromatic Chemotypes with Poor Solubility and Permeability

Some allosteric ligands are dominated by flat aromatic scaffolds that provide favorable hydrophobic contacts within their binding pockets. However, excessive aromatic surface area, limited three-dimensional character, or unfavorable polar and ionization properties can contribute to poor aqueous solubility and cellular permeability. These limitations may become more pronounced after the ligand is connected to a linker and an E3 ligase recruiter.

BOC Sciences evaluates the relationship between scaffold structure, binding interactions, and molecular properties during warhead optimization. Rather than simply adding polar groups, our design strategy considers how modifications affect pocket occupancy, conformational preferences, and the orientation of key substituents.

Allosteric Engagement That Fails to Form a Productive Ternary Complex

Strong binary binding between an allosteric warhead and its target protein does not guarantee effective PROTAC activity. After linker and E3 ligase ligand attachment, the resulting molecule must bring the target and E3 ligase into a suitable spatial arrangement. An unfavorable warhead orientation, linker trajectory, or steric relationship between the two proteins may prevent productive ternary complex formation.

BOC Sciences evaluates warhead design in the context of the complete degrader architecture. We consider the orientation of the ligand within its binding pocket, the location of the proposed linker attachment point, the accessibility of the surrounding protein surface, and the potential interaction geometry with the recruited E3 ligase.

Facing Challenges in Allosteric Warhead Design?

From difficult-to-identify binding pockets and weak ligand affinity to linker attachment and ternary complex formation, BOC Sciences can help address your allosteric warhead design challenges. Tell us about your target and research needs, and let our experts help develop a suitable solution.

Tell Us Your Challenges

Workflow

Our Allosteric Warhead Design Workflow

01

Project Consultation and Target Biology Assessment

We review target biology, domain architecture, known ligands, prior screening data, and the degradation question you are trying to answer. The output is a written site hypothesis and a clear decision on whether an allosteric route is justified.

02

Allosteric Binding-Site Identification and Prioritization

Available structures and models are analyzed together with ensemble sampling to map candidate pockets. Each site is scored for druggability, conservation, conformational accessibility, and exit vector quality, then ranked against the alternatives.

03

Ligand Discovery, Screening, and Binding Validation

Hit finding runs on the route that fits the pocket class, and every hit is confirmed in vitro and biophysically before optimization. Site assignment, binding mode, and conformational effect are documented at this stage, not assumed.

04

Structure-Guided Warhead Optimization

Affinity, pose retention, and attachment-point quality are optimized together with matched-pair controls built alongside. Optimized warheads move directly into PROTAC design services for linker and E3 ligand assembly.

Applications

Applications of Allosteric Warhead Design

Resistance-Associated Kinase Degrader Development

Allosteric warheads can provide alternative binding strategies for kinase targets carrying mutations that affect conventional ATP-site ligand recognition. By targeting distinct regulatory pockets, researchers can investigate degrader designs that retain target engagement in selected resistance-associated protein variants.

Selective Degradation of Closely Related Protein Family Members

Structural differences in non-orthosteric pockets may provide opportunities to distinguish homologous proteins that share highly conserved catalytic regions. Allosteric warhead optimization can therefore support selective target recognition and help explore degradation strategies for individual protein family members.

Targeting Regulatory Enzymes and Phosphatases

Some regulatory enzymes and phosphatases have complex domain arrangements or challenging catalytic pockets. Allosteric warheads can provide alternative binding opportunities through regulatory regions and non-catalytic structural features, supporting the development of degraders that remove the entire target protein.

Membrane Receptor and Intracellular Signaling Protein Degradation

Allosteric ligand discovery can be applied to selected receptor domains and intracellular signaling proteins where regulatory pockets influence conformational states, protein interactions, or signaling behavior. Target accessibility, ligand-binding geometry, and the intended degradation pathway are considered during warhead design.

Need an Application-Specific Allosteric Warhead for PROTAC Development?

BOC Sciences develops tailored allosteric warhead design strategies based on your target protein, research objectives, and intended applications. By considering target biology, binding-site characteristics, ligand properties, and degradation requirements, our experts can help identify and optimize suitable allosteric warheads for your PROTAC development program.

Discuss Your Application

Advantages

Why Are Allosteric Warheads Valuable for PROTAC Development?

Overcoming Resistance at Orthosteric Binding Sites

Mutations that abolish orthosteric inhibitor binding often leave allosteric pockets untouched. A warhead that approaches the protein from a different surface keeps working where the active-site route has closed.

Improving Selectivity Among Homologous Protein Targets

Allosteric pockets are less conserved than active sites, so degraders built on them can separate isoforms and close homologs that orthosteric warheads cannot distinguish. PROTAC selectivity evaluation turns that separation into evidence.

Enabling Degradation of Non-Catalytic Protein Functions

Degradation removes scaffolding, transport, and interaction functions that inhibition never touches, and an allosteric warhead can reach proteins that have no catalytic site at all.

Expanding the Druggable Space Beyond Conventional Binding Pockets

Cryptic and transient cavities extend ligandability to transcription factors, phosphatases, and adaptor proteins that offer no conventional druggable site.

Why Us

Why Choose BOC Sciences for Allosteric Warhead Design?

Integrated Computational and Experimental Design Capabilities

Pocket detection, docking, dynamics, biophysics, and structure determination run inside one team, so a predicted pocket and its experimental confirmation are never separated by a handoff.

Warhead, Linker and Building Block Supply

Design work is backed by an in-house supply of warhead chemotypes, linker library building blocks, and E3 ligase ligand-linker conjugate intermediates, which shortens the path from a designed analog to a synthesized one.

Structure-Guided Ligand Discovery and Optimization

Every optimization cycle is anchored to structural data, whether it comes from a co-crystal, a cryo-EM map, or an NMR-derived epitope.

PROTAC-Oriented Warhead Evaluation Beyond Binding Affinity

Warheads are judged on ternary complex formation, degradation potency, and selectivity, not on binding alone, through degradation ability assay readouts from the same compound batch.

Frequently Asked Questions (FAQ)

Frequently Asked Questions

Still have questions?

Contact Us

A suitable allosteric PROTAC warhead should bind effectively to a non-orthosteric site on the target protein and possess structural features that allow further chemical modification. Importantly, an allosteric warhead does not necessarily need to inhibit or activate its target. Even a functionally silent ligand may serve as a useful target-binding element if it maintains sufficient target engagement. Its suitability should be assessed based on binding affinity, binding mode, target selectivity, linker attachment position, and binding retention after linker conjugation. Productive ternary complex formation and protein degradation should ultimately be considered when evaluating its potential for PROTAC development.

When an allosteric warhead binds to a non-orthosteric site, it may induce or stabilize a particular protein conformation, potentially altering surface topology, domain arrangement, and protein-protein interaction interfaces. These changes may influence the spatial relationship between the target protein and the recruited E3 ubiquitin ligase, affecting ternary complex formation. The PROTAC recruits the E3 ligase through its E3-binding moiety, bringing it into proximity with the target. Productive complex formation can promote target ubiquitination and subsequent proteasomal degradation. However, allosteric binding does not automatically improve degradation efficiency, making experimental validation essential.

Allosteric warheads can provide an alternative target-binding strategy when mutations in an orthosteric pocket reduce the binding affinity of conventional inhibitors or orthosteric warheads. By engaging a distinct binding region, an allosteric warhead may retain target recognition even when the original binding site is affected. This approach is particularly relevant to kinase targets with resistance-associated mutations in ATP-binding regions. However, its effectiveness depends on whether the mutation also influences the structure, accessibility, or conformational behavior of the allosteric pocket. Evaluating both wild-type and relevant mutant proteins through binding, ternary complex, and degradation assays is therefore important.

When established allosteric inhibitors are unavailable, ligand discovery can begin with protein structural analysis and identification of potential allosteric pockets. Computational and experimental approaches, including molecular docking, virtual screening, molecular dynamics simulation, and fragment-based screening, can be combined to identify candidate ligands. Selected hits are then evaluated through biophysical or biochemical binding assays to confirm direct target engagement and investigate their binding modes. BOC Sciences integrates ready-to-screen ligand libraries, computational screening platforms, and experimental evaluation capabilities to support novel allosteric ligand discovery. Importantly, screening should consider the potential of a compound to serve as a PROTAC target-binding element rather than relying exclusively on its inhibitory activity.

BOC Sciences evaluates ligand-binding conformations, key amino acid interactions, and structurally accessible regions for linker attachment through structural analysis, molecular modeling, and structure-activity relationship studies. Based on these findings, scaffold modification, functional group adjustment, and substituent optimization can be explored to improve binding affinity, selectivity, and physicochemical properties while preserving essential target-recognition interactions. Because the binding behavior of a free ligand may differ after linker conjugation, the modified warhead should also be evaluated for target engagement. Further integration with linker design, ternary complex assessment, and protein degradation studies helps optimize the complete PROTAC architecture rather than evaluating the warhead in isolation.

* PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.

  • Verification code
Inquiry Basket